5 . € millions 2019 31.12.2018 Acquisitions/Disposals Other movements 31.12.2019 Redken/PureOlogy 666.7 3.5 10.8 681.0 L'Oréal Professionnel/Kérastase 415.4 5.6 421.0 Matrix 405.8 7.3 413.1 Decléor and Carita 137.4 - 137.4 Other 3.1 - 0.1 3.2 Professio nal Products Total 1,628.4 3.5 23.7 1,655.7 Mass Market make-up 1,019.6 18.3 1,037.9 L'Oréal Paris 899.1 11.0 910.2 Garnier 513.2 -9.3 503.9 Stylenanda 429.5 1.3 430.7 NYX Professional Makeup 322.6 5.1 327.8 LaSCAD 158.3 - 158.3 Other 353.8 3.0 356.8 Consu mer Products Total 3,696.1 29.4 3,725.5 Lancôme 825.3 7.3 832.6 IT Cosmetics 775.9 11.4 787.4 YSL Beauté 533.2 2.9 536.1 Perfumes 454.9 2.8 457.7 Urban   Decay 150.2 2.5 152.7 Shu Uemura 137.9 5.3 143.1 L'Oréal Beauty Device (1) 71.3 -46.7 24.6 Other 65.0 2.6 67.5 L'Oréal Luxe Total 3,013.7 - -12.0 3,001.8 CeraVe 629.5 5.9 635.4 Vichy/Dermablend 358.4 -34.6 323.8 La Roche-Posay 161.4 7.6 169.0 Other 73.4 1.1 74.5 Active Cosmetics Total 1,222.7 -20.1 1,202.7 Other 36.1 -36.1 - GROUP TOTAL 9,597.1 3.5 -15.0 9,585.6 (1) This Cash Generating Unit mainly concerns Clarisonic. No significant acquisitions or disposals took place during this financial year. Other movements mainly reflect the positive impact of changes in exchange rates for €65.4  million, as well as the recognition of impairment losses on Clarisonic (€47  million) and Roger & Gallet (€36 million). The accumulated impairment losses relating to L’Oréal Beauty Device, Magic, and Softsheen-Carson amounted to €279.7  million, €153.0 million, and €149.3 mill ion, respectively at 31 December 2019. 314 L ’ ORÉAL I UNIVERSAL REGISTRATION DOCUMENT 2021 2021 CONSOLIDATED FINANCIAL STATEMENTS Notes to the consolidated financial statements